Adcytherix

Drug Discovery · Marseille, France · Founded 2024 · Privately Held (backing)

Developer of an antibody-drug conjugate platform designed to address resistance and improve safety in cancer therapy through novel payload innovation. Adcytherix is based in Marseille, France and was founded in 2024. It was valued at $213 million at its early-stage round in Jul 2025, the last priced event on record. It has raised $161 million across 2 recorded rounds; the latest was a $126 million Series A in Jul 2025.

PMV mark · valuation
$213.3M
Oct 2026
Priced at
its early-stage round
Jul 2025
Total raised
$160.8M
Last round
Early Stage VC (Series A)
Jul 2025
What is Adcytherix worth?
$213.3MPrivateMarketView mark · Oct 2026

Valued at $213.3M at its early-stage round, Jul 2025. Nothing has traded since.

Free account
More of Adcytherix with a free account
  • ·The complete investor list: 13 names
  • ·Watch Adcytherix: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Adcytherix funding history

2 rounds
DateRoundRaisedPost-money
Jul 2025Early Stage VC (Series A)$126.3M▮
Jun 2024Seed Round$38.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Adcytherix valuation

Adcytherix was valued at $213 million at its early-stage round in Jul 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Adcytherix raised?

Adcytherix has raised $161 million across 2 recorded rounds since 2024. The largest was a $38 million seed round in Jun 2024; the most recent was a $126 million Series A in Jul 2025.

Comparable companies

Comparable drug discovery names by valuation on PrivateMarketView: Adcendo ($210 million), Plexium ($200 million) and Ajax Therapeutics ($193 million).

How Adcytherix's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Adcytherix, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Adcytherix

What is Adcytherix worth?
Adcytherix is valued at $213.3M as of Oct 2026. Valued at $213.3M at its early-stage round, Jul 2025. Nothing has traded since.
How much has Adcytherix raised?
Adcytherix has raised $160.8M in total funding across 2 recorded rounds.
When did Adcytherix last raise?
Adcytherix last raised in Jul 2025 (Early Stage VC (Series A)), raising $126.3M.